{
  "description": "Intepretation of OncotypeDX DCIS (Ductal Carcinoma In Situ) Recurrence Score",
  "compose": {
    "include": [ {
      "system": "http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-OncotypeDxDCISRiskScoreInterpretationCS",
      "concept": [ {
        "code": "low_risk",
        "display": "Recurrence Score lower than 38: The cancer has a low risk of recurrence. The benefit of chemotherapy is likely to be small and will not outweigh the risks of side effects."
      }, {
        "code": "intermediate_risk",
        "display": "Recurrence Score of 39 up to and including 54: The cancer has an intermediate risk of recurrence. It’s unclear whether the benefits of chemotherapy outweigh the risks of side effects."
      }, {
        "code": "high_risk",
        "display": "Recurrence Score greater than or equal to 55: The cancer has a high risk of recurrence, and the benefits of chemotherapy are likely to be greater than the risks of side effects."
      } ]
    } ]
  },
  "_filename": "ValueSet-oncology-OncotypeDxDCISRiskScoreInterpretationVS.json",
  "package_name": "hl7.fhir.us.breastcancer",
  "date": "2018-04-01T00:00:00+11:00",
  "publisher": "The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC)",
  "name": "OncotypeDxDCISRiskScoreInterpretationVS",
  "type": null,
  "experimental": null,
  "resourceType": "ValueSet",
  "title": "BC OncotypeDxDCISRiskScoreInterpretationVS ValueSet",
  "package_version": "0.1.0",
  "status": "draft",
  "id": "bce7697f-d7cb-43d8-96f6-04995c84e925",
  "kind": null,
  "url": "http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-OncotypeDxDCISRiskScoreInterpretationVS",
  "identifier": [ {
    "value": "oncology.OncotypeDxDCISRiskScoreInterpretationVS",
    "system": "http://hl7.org/fhir/us/breastcancer"
  } ],
  "version": "0.1.0",
  "contact": [ {
    "telecom": [ {
      "value": "http://standardhealthrecord.org",
      "system": "url"
    } ]
  } ]
}